The Neuro-CERVO Alliance Partners with Montreal-based AI Company Simmunome to Understand Neurological Disease Mechanisms and Accelerate Drug Development

MONTREAL, Canada, July 18, 2023 In the newly established initiative, the Neuro-CERVO Alliance for Drug Discovery (NCADD) is welcoming a new Montreal-based private partner, Simmunome, to untangle biological pathways and…

Read the article